Unknown

Dataset Information

0

New Arylethanolimidazole Derivatives as HO-1 Inhibitors with Cytotoxicity against MCF-7 Breast Cancer Cells.

ABSTRACT: In this paper, a novel series of imidazole-based heme oxygenase-1 (HO-1) inhibitors is reported. These compounds were obtained by modifications of previously described high potent and selective arylethanolimidazoles. In particular, simplification of the central linker and repositioning of the hydrophobic portion were carried out. Results indicate that a hydroxyl group in the central region is crucial for the potency as well as the spatial distribution of the hydrophobic portion. Docking studies revealed a similar interaction of the classical HO-1 inhibitors with the active site of the protein. The most potent and selective compound (5a) was tested for its potential cytotoxic activity against hormone-sensitive and hormone-resistant breast cancer cell lines (MCF-7 and MDA-MB-231).

SUBMITTER: Ciaffaglione V 

PROVIDER: S-EPMC7139504 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

New Arylethanolimidazole Derivatives as HO-1 Inhibitors with Cytotoxicity against MCF-7 Breast Cancer Cells.

Ciaffaglione Valeria V   Intagliata Sebastiano S   Pittalà Valeria V   Marrazzo Agostino A   Sorrenti Valeria V   Vanella Luca L   Rescifina Antonio A   Floresta Giuseppe G   Sultan Ameera A   Greish Khaled K   Salerno Loredana L  

International journal of molecular sciences 20200311 6

In this paper, a novel series of imidazole-based heme oxygenase-1 (HO-1) inhibitors is reported. These compounds were obtained by modifications of previously described high potent and selective arylethanolimidazoles. In particular, simplification of the central linker and repositioning of the hydrophobic portion were carried out. Results indicate that a hydroxyl group in the central region is crucial for the potency as well as the spatial distribution of the hydrophobic portion. Docking studies  ...[more]

Similar Datasets

Unknown Synthesis, Structural Characterization, and Cytotoxic Activity of New Benzo[d]imidazo[2,1-b]thiazole Derivatives Against MCF-7 Breast Cancer Cells.
| S-EPMC9872551 | biostudies-literature
Unknown Novel psoralen derivatives as anti-breast cancer agents and their light-activated cytotoxicity against HER2 positive breast cancer cells.
| S-EPMC9356065 | biostudies-literature
Unknown Hybrid molecules of protoflavones and spirooxindole derivatives with selective cytotoxicity against triple-negative breast cancer cells.
| S-EPMC10507806 | biostudies-literature
Unknown Curcumin and Its New Derivatives: Correlation between Cytotoxicity against Breast Cancer Cell Lines, Degradation of PTP1B Phosphatase and ROS Generation.
| S-EPMC8508995 | biostudies-literature
Unknown Synergistic Cytotoxicity of Renieramycin M and Doxorubicin in MCF-7 Breast Cancer Cells.
| S-EPMC6780817 | biostudies-other
Unknown Cytotoxicity and apoptosis induced by a plumbagin derivative in estrogen positive MCF-7 breast cancer cells.
| S-EPMC3894702 | biostudies-literature
Unknown Cytotoxicity of Fenugreek Sprout and Seed Extracts and Their Bioactive Constituents on MCF-7 Breast Cancer Cells.
| S-EPMC8879394 | biostudies-literature
Unknown Synthesis, cytotoxicity and antitumour mechanism investigations of polyoxometalate doped silica nanospheres on breast cancer MCF-7 cells.
| S-EPMC5509251 | biostudies-literature
Unknown AKT Inhibitors: New Weapons in the Fight Against Breast Cancer?
| S-EPMC8118639 | biostudies-literature
Unknown Ligand substituent effect on the cytotoxicity activity of two new copper(ii) complexes bearing 8-hydroxyquinoline derivatives: validated by MTT assay and apoptosis in MCF-7 cancer cell line (human breast cancer).
| S-EPMC8697721 | biostudies-literature